Evaluation of safety and efficacy of transdermal therapeutic system-fentanyl in adult patients with gynecological cancer-related pain

Journal of the Medical Association of Thailand

Volumn 87, Issue 3, 2004, Pages 319-325

  Lorvidhaya, Vicharn ^a   Srisomboon, Jatuphol ^a   Cheewakriangkrai, Chalong ^a   Katanyoo, Kanyarat ^a   Suprapaphorn, Prapaporn ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

Efficacy; Gynecological Cancer; Pain; TTS Fentanyl

Indexed keywords

BUPRENORPHINE; CODEINE; DIAMORPHINE; FENTANYL; HYDROMORPHONE; LEVORPHANOL; MORPHINE; OPIATE; OXYCODONE; OXYMORPHONE; PETHIDINE;

ADULT; ANALGESIA; ANALGESIC ACTIVITY; ANOREXIA; ARTICLE; CANCER PAIN; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; FEASIBILITY STUDY; FLATULENCE; GYNECOLOGIC CANCER; HUMAN; NAUSEA; PAIN ASSESSMENT; PATIENT MONITORING; PROSPECTIVE STUDY; PRURITUS; VISUAL ANALOG SCALE; VOMITING; CHRONIC DISEASE; DRUG DELIVERY SYSTEM; EVALUATION; FEMALE; FEMALE GENITAL TRACT TUMOR; INTRADERMAL DRUG ADMINISTRATION; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PAIN; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADULT; CHRONIC DISEASE; DRUG DELIVERY SYSTEMS; FEMALE; FENTANYL; GENITAL NEOPLASMS, FEMALE; HUMANS; MIDDLE AGED; MORPHINE; PAIN; PAIN MEASUREMENT; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 2642515589     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Mather LE. Clinical pharmacokinetics of fentanyl and its newer derivatives. Clin Pharmacokinetic 1983; 8: 422-66.
2. Wuster M, Schutz R, Herz A. The direction of opioid agonists towards mu, delta, and epsilon-receptors in the VAS deference of the mouse and rat. Life Sci 1980; 27: 163-70.
3. Stanley TH, Webster L. Anesthesia requirements and cardiovascular effects of fentanyl-oxygen and fentanyl-diazepam-oxygen anesthesia in man. Anesth Analg 1978; 57: 411-6.
4. Hall GM. Fentanyl and the metabolic response to surgery. Br J Anaesth 1980; 52: 562.
5. Bonica JJ. Treatment of cancer pain: Current status and future needs. Pain 1984; 2: 196.
6. Foley KM. Current issues in the management of cancer pain: Memorial sloan-Kettering Cancer Center. National Institute of Drug Abuse Research Monograph Series 1981; 36: 169-81.
7. Austin KL, Stapleton JV, Mather LE. Multiple intramuscular injections: Major source of variability in analgesic response to meperidine. Pain 1980; 8: 47.
8. McGivney WT, Cooks GM. The care of patients with severe chronic pain and terminal illness. JAMA 1984; 252: 1182-8.
9. Homesley HD, Welander CE, Muss HB. Dosage range study of morphine sulphate controlled release. Am J Clin Oncol 1986; 9: 449-53.
10. Foley KM. The treatment of cancer pain. New Eng J Med 1985; 31B: 84-95.
11. Amer S, Amer B. Differential effects of epidural morphine in the treatment of cancer-related pain. Acta Anaesthesiol Scand 1985; 29: 32-6.
12. Zech D, Grond S, Breitenbach H, Hertel D. Transdermal fentanyl in the treatment of tumour pain. A prospective study in 42 patients with malignant disorders. Pain 1992; 50: 293-301.
13. Ahmedzai S, Allan E, Fallon D, et al. Transdermal fentanyl in cancer pain. J Drug Dev 1994; 6: 93-7.
14. Leelanuntakit S. Management of cancer-related pain with transdermal fentanyl. J Med Assoc Thai 1996; 76: 342-5.
15. Takeda F. Results of field-testing in Japan of the WHO draft interim guidelines on relief of cancer pain. Pain Clin 1986; 1: 83.
16. Miser AW, Narang PK, Dothage JA, Young RC, Sindelar W, Miser JS. Transdermal fentanyl for pain control in patients with cancer. Pain 1989; 37: 15-22.
17. Herbst LH, Strause LG. Transdermal fentanyl use in hospice home-care patients with chronic cancer pain. J Pain Symptom Manage 1992; 7 (Suppl 3): S54-S57.
18. Zech DF, Lehmann KA, Grond S. A new treatment option for chronic cancer pain. Eur J Palliat Care 1994; 1: 26-30.
19. Fainsinger RL, Bruera E. How should we use transdermal fentanyl (TF) for pain management in palliative care patients? J Palliate Care 1996; 12: 48-53.
20. Sloan AP, Moulin ED, Hays H. A clinical evaluation of transdermal therapeutic system fentanyl for the treatment of cancer pain. J Pain Symptom Manage 1998; 16: 102-11.
21. Donner B, Zenz M, Tryba M, Strumpf M. Direct conversion from oral morphine to transdermal fentanyl: A multicenter study in patients with cancer pain. Pain 1996; 64: 527-34.
22. Simmonds MA, Richenbacher J. Transdermal fentanyl: Long-term analgesic studies. J Pain Symptom Manage 1992; 7: 36-9.